This article provides an in-depth analysis of the sales of adaptogenic drugs in the pharmaceutical market of Uzbekistan for the period 2021-2024. Key trends, changes in the market structure, the dynamics of the range of pharmaceutical forms, pricing policy, and further development prospects were studied. Special attention was paid to import dependence, localization of production, and the introduction of new technologies. The presented data are visualized in the form of diagrams and graphs.
Analysis of The Sale of Adaptogenic Drugs in The Republic of Uzbekistan
DOI:
Keywords:
Adaptogenic drugs
pharmaceutical market
import substitution
Abstract
References
Kurkin V.A., Petrukhina I.K., Akushskaya A.S. Study of the nomenclature of adaptogenic drugs presented on the pharmaceutical market of the Russian Federation fundamental research No. 8, 2014, pp. 898-902
H. K. Bekchanov, kh. J. Kambarov, l. M. Jalilov, kh. M. Djalilova, l. S’h. Yakubova, j. S’h. S’hoymurodov. Development of the composite ad technology of capsules of the medicinal preparation containing the dry yextract “s’harq tab1bi” journal of human university, (natural sciences) vol. 48. No. 8. August 2021, 176-185.
Evolution of the adaptogenic concept from traditional use to medical systems: pharmacology of stress- and ging-related diseases. Review a r t i c l e wileyonlinelibrary.com/journal/med med res rev. 2021; 41:630–703.
State Register of Medicines and Medical Devices Registered in the Republic of Uzbekistan - No. 25 of 2021.